Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

ADCT - ADC Therapeutics SA Financial Statements | Finranks

Home

/

ADCT

A

ADC Therapeutics SA (ADCT)

NYQ – Real Time Price. Currency in USD

1.17

-0.01 (-0.42%)

Market open: Aug 12, 2026, 10:08 AM EDT

1.16

-0.02 (-1.69%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

81M

71M

70M

210M

Cost of goods sold

-8M

-9M

-6M

-6M

Gross Profit

74M

62M

64M

204M

Operating expenses (excl. COGS)

-182M

-192M

-228M

-325M

Operating Income

-108M

-131M

-164M

-121M

Non-operating income, total

-34M

-27M

-32M

-26M

Pretax income

-143M

-157M

-196M

-147M

Equity in earnings

0

-2M

-6M

-10M

Taxes

157K

897K

-38M

130K

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-143M

-158M

-240M

-157M

Discontinued operations

0

0

0

0

Net income

-143M

-158M

-240M

-157M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

324M+0.6%

322M-9.2%

355M-27.7%

491M

Total current assets

306M

307M

336M

435M

Total non-current assets

18M

15M

18M

56M

Total liabilities

510M-2.8%

525M+4.3%

503M+22.3%

411M

Total current liabilities

70M

80M

68M

82M

Total non-current liabilities

440M

444M

435M

329M

Total equity

-186M

-203M

-148M

79M

Total liabilities & shareholders' equities

324M

322M

355M

491M

Total debt

440M+257.4%

123M-1.1%

124M+6.0%

117M

Name

2025

2024

2023

2022

Cash from operating activities

-141M

-124M

-119M

-138M

Cash from investing activities

395K

-867K

-3M

-687K

Cash from financing activities

151M

97M

74M

-897K

Free cash flow

-141M-13.4%

-125M-2.3%

-122M+12.3%

-139M